Stamibio Lotion Italia - italiano - myHealthbox

stamibio lotion

guna - roe extract, gingko biloba, salvia officinalis, vitamina e - lozione - aqua/water, alcohol denat., butylene glycol, glycerin, salvia officinalis extract, ginkgo biloba extract, cinnamomunm zeylanicum extract, ppg-26-buteth-26, peg-40 hydrogenated castor oil, apigenin, oleanolic acid, biotinoyl tripeptide-1, roe extract, ethyl - cosmetici - creme

PRID DELTA 1,55 G Italia - italiano - Ministero della Salute

prid delta 1,55 g

ceva salute animale s.p.a. - progesterone - progesterone - 1.55 grammo (i), progesterone - 1.55 g - progesterone

Dimethyl fumarate Mylan Unione Europea - italiano - EMA (European Medicines Agency)

dimethyl fumarate mylan

mylan ireland limited - dimetilfumarato - sclerosi multipla recidivante-remittente - immunosoppressori - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Polpharma Unione Europea - italiano - EMA (European Medicines Agency)

dimethyl fumarate polpharma

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetilfumarato - sclerosi multipla recidivante-remittente - immunosoppressori - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Neuraxpharm Unione Europea - italiano - EMA (European Medicines Agency)

dimethyl fumarate neuraxpharm

laboratorios lesvi s.l. - dimetilfumarato - sclerosi multipla recidivante-remittente - immunosoppressori - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Teva Unione Europea - italiano - EMA (European Medicines Agency)

dimethyl fumarate teva

teva gmbh - dimetilfumarato - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosoppressori - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Dimethyl fumarate Accord Unione Europea - italiano - EMA (European Medicines Agency)

dimethyl fumarate accord

accord healthcare s.l.u. - dimetilfumarato - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosoppressori - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Methylphenidat-Mepha 18 mg Retardtabletten Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

methylphenidat-mepha 18 mg retardtabletten

mepha pharma ag - methylphenidati hydrochloridum - retardtabletten - methylphenidati hydrochloridum 18 mg, zucchero sfere corrisp. sintetico 10.9 mg, hypromellosum, talco, acido hydrochloridum, ethylcellulosum, hydroxypropylcellulosum, triethylis citras, hypromellosi acetas succinas, carmellosum natricum corrisp. sodio 3.87 mg, cellulosum microcristallinum, magnesio stearas, silice colloidalis anhydrica, Überzug: poli(alcole vinylicus), talco, macrogolum 3350, e 171, e 172 (giallo), acido hydrochloridum, per compresso haze. - centrale efficiente ad azione prolungata - synthetika

Methylphenidat-Mepha 27 mg Retardtabletten Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

methylphenidat-mepha 27 mg retardtabletten

mepha pharma ag - methylphenidati hydrochloridum - retardtabletten - methylphenidati hydrochloridum 27 mg, zucchero sfere corrisp. sintetico 16.36 mg, hypromellosum, talco, acido hydrochloridum, ethylcellulosum, hydroxypropylcellulosum, triethylis citras, hypromellosi acetas succinas, carmellosum natricum corrisp. sodio 5.78 mg, cellulosum microcristallinum, magnesio stearas, silice colloidalis anhydrica, Überzug: poli(alcole vinylicus), talco, macrogolum 3350, e 172 (giallo), acido hydrochloridum, per compresso haze. - centrale efficiente ad azione prolungata - synthetika

Methylphenidat-Mepha 36 mg Retardtabletten Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

methylphenidat-mepha 36 mg retardtabletten

mepha pharma ag - methylphenidati hydrochloridum - retardtabletten - methylphenidati hydrochloridum 36 mg, zucchero sfere corrisp. la biomassa 21.8 mg, hypromellosum, talco, acido hydrochloridum, ethylcellulosum, hydroxypropylcellulosum, triethylis citras, hypromellosi acetas succinas, carmellosum natricum corrisp. sodio 7.71 mg, cellulosum microcristallinum, magnesio stearas, silice colloidalis anhydrica, Überzug: poli(alcole vinylicus), talco, macrogolum 3350, e 171, acido hydrochloridum, per compresso haze. - centrale efficiente ad azione prolungata - synthetika